CRBU Caribou Biosciences, Inc. - Common Stock
$1.66
가격 · 8월 19, 2026
기준 재무 정보 8월 13, 2026
52주 범위
$1–$4
13% of range
애널리스트 평점
BUY
14 analysts
목표 주가
$12
+625% upside
P/E (TTM)
-1.0
ROE
-102.8%
순이익률
-1327.4%
CRBU 주식 스냅샷 가격, 시가총액, P/E, EPS, ROE, 부채/자본, 52주 범위
가격
$1.66
시가총액
$157M
P/E (TTM)
-1.0
EPS (TTM)
$-1.59
매출 (TTM)
$11M
배당 수익률
—
ROE
-102.8%
부채/자본
—
52주 범위
$1 – $4
CRBU 주가 차트 기술 지표가 포함된 일일 OHLCV — 팬, 확대/축소 및 보기 사용자 정의
Configure
10년 성과 매출, 순이익, 마진 및 EPS 추세
매출 및 순이익
$11M
2019-12-31
→
2025-12-31
EPS
$-1.59
2021-12-31
→
2025-12-31
잉여현금흐름
$-112M
2021-12-31
→
2025-12-31
마진
-1327.4%
가치 평가 P/E, P/S, P/B, EV/EBITDA 비율 — 주식이 비싼가요, 싼가요?
지표
5년 추세
CRBU
동종업계 중앙값
P/E (TTM)
-1.0
1.2
P/S (TTM)
14.1
14.2
P/B
1.3
1.2
Price / FCF (주가 / FCF)
-1.4
—
수익성 총, 영업 및 순이익률; ROE, ROA, ROIC
지표
5년 추세
CRBU
동종업계 중앙값
Operating Margin (영업이익률)
-1329.4%
—
Net Profit Margin (순이익률)
-1327.4%
-1189.1%
ROA
-60.6%
-58.9%
ROE
-102.8%
-79.0%
ROIC
-121.0%
—
재무 건전성 부채, 유동성, 지급능력 — 대차대조표 건전성
지표
5년 추세
CRBU
동종업계 중앙값
Current Ratio (유동비율)
5.7
5.4
Quick Ratio (당좌 비율)
0.5
—
성장 매출, EPS 및 순이익 성장률: YoY, 3년 CAGR, 5년 CAGR
지표
5년 추세
CRBU
동종업계 중앙값
Revenue YoY (매출 YoY)
11.7%
—
Revenue CAGR 3Y (매출 CAGR 3년)
-7.0%
—
Revenue CAGR 5Y (매출 CAGR 5년)
-2.0%
—
자본 효율성 자산 회전율, 재고 회전율, 매출채권 회전율
지표
5년 추세
CRBU
동종업계 중앙값
CRBU 분석가 합의 강세 및 약세 애널리스트 의견, 12개월 목표 주가, 상승 여력
매수
14 명의 애널리스트
- 적극 매수 5 35.7%
- 매수 8 57.1%
- 보유 1 7.1%
- 매도 0 0.0%
- 적극 매도 0 0.0%
12개월 목표 주가
7 명의 애널리스트 · 2026-08-14
중앙값
$10.00
← 모든 목표가 하회
$1.66
저가
$4.00
고가
$32.00
중앙값 목표
$10.00
+504.2%
평균 목표
$12.00
+625.1%
실적 기록 EPS 실제 vs 예상, 서프라이즈 %, 달성률, 다음 실적 발표일
평균 서프라이즈
0.02%
| 기간 | EPS Actual | EPS 예상 | 서프라이즈 |
|---|---|---|---|
| 2026년 6월 30일 | $-0.24 | $-0.32 | 0.08% |
| 2026년 3월 31일 | $-0.26 | $-0.32 | 0.06% |
| 2025년 12월 31일 | $-0.28 | $-0.32 | 0.04% |
| 2025년 9월 30일 | $-0.30 | $-0.37 | 0.07% |
| 2025년 6월 30일 | $-0.58 | $-0.40 | -0.18% |
| 2025년 3월 31일 | $-0.43 | $-0.45 | 0.02% |
동종 기업 비교(GICS 하위 산업) 주요 지표 대 섹터 동종 기업
| 티커 | 시가총액 | P/E | 매출 YoY | 순이익률 | ROE | 매출 총이익률 |
|---|---|---|---|---|---|---|
| CRBU | $151M | -1.0 | 11.7% | -1327.4% | -102.8% | — |
| CHRS | $172M | 1.0 | 59.8% | 398.4% | 185.8% | — |
| NKTX | $131M | -1.3 | — | — | -31.1% | — |
| OKUR | — | -0.7 | — | -1733.7% | -88.6% | — |
| CNTB | $159M | -2.8 | -99.8% | -86687.5% | -97.9% | — |
| TNYA | $154M | -1.2 | — | — | -81.2% | — |
| CNTN | $112M | -2.7 | — | — | -18.0% | — |
| HUMA | — | — | — | — | — | — |
| UNCY | $128M | -3.5 | -29.0% | — | -113.9% | — |
| EQ | $95M | -4.0 | 13.9% | — | -133.1% | — |
전체 기본 지표 연도별 모든 지표 — 손익계산서, 대차대조표, 현금흐름
손익계산서 15
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $11M | $10M | $34M | $14M | $10M | $12M | |
| R&D Expense | $109M | $130M | $112M | $82M | $52M | $34M | |
| SG&A Expense | $38M | $46M | $38M | $38M | $24M | $14M | |
| Operating Expenses | $160M | $177M | $151M | $120M | $77M | $48M | |
| Operating Income | $-148M | $-167M | $-116M | $-106M | $-67M | $-36M | |
| Interest Expense | · | · | · | · | $8.0K | $20.0K | |
| Other Non-op | $-331.0K | $18M | $14M | $7M | $377.0K | $-3.0K | |
| Pretax Income | $-149M | $-149M | $-102M | $-99M | $-67M | $-36M | |
| Income Tax | $-550.0K | $-9.0K | $193.0K | $70.0K | $321.0K | $-2M | |
| Net Income | $-148M | $-149M | $-102M | $-99M | $-67M | $-34M | |
| EPS (Basic) | $-1.59 | $-1.65 | $-1.38 | $-1.64 | $-2.11 | · | |
| EPS (Diluted) | $-1.59 | $-1.65 | $-1.38 | $-1.64 | $-2.11 | · | |
| Shares (Basic) | 93,389,283 | 90,317,925 | 73,807,597 | 60,801,133 | 31,663,243 | · | |
| Shares (Diluted) | 93,389,283 | 90,317,925 | 73,807,597 | 60,801,133 | 31,663,243 | · | |
| EBITDA | $-145M | $-163M | $-113M | $-105M | $-66M | · |
대차대조표 23
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $12M | $16M | $51M | $58M | $240M | $16M | |
| Short-term Investments | · | · | · | · | $135M | $0 | |
| Receivables | $69.0K | $265.0K | $148.0K | $202.0K | $1M | $150.0K | |
| Prepaid Expense | $3M | $7M | $6M | $8M | $7M | $3M | |
| Current Assets | $145M | $219M | $339M | $260M | $391M | $24M | |
| PP&E (Net) | $7M | $19M | $18M | $11M | $5M | $4M | |
| PP&E (Gross) | $20M | $32M | $27M | $16M | $9M | $7M | |
| Accum. Depreciation | $14M | $13M | $9M | $6M | $4M | $3M | |
| Other Non-current Assets | $2M | $6M | $2M | $2M | $975.0K | $612.0K | |
| Total Assets | $175M | $313M | $432M | $374M | $442M | $36M | |
| Accounts Payable | $6M | $2M | $3M | $1M | $4M | $3M | |
| Accrued Liabilities | $17M | $24M | $21M | $16M | $13M | $9M | |
| Current Liabilities | $25M | $31M | $28M | $28M | $26M | $12M | |
| Capital Leases | $26M | $25M | $26M | $27M | $0 | · | |
| Deferred Tax | $0 | $548.0K | $557.0K | $381.0K | $476.0K | $155.0K | |
| Total Liabilities | $53M | $60M | $64M | $73M | $55M | $18M | |
| Common Stock | $9.0K | $9.0K | $8.0K | $6.0K | $6.0K | $1.0K | |
| Paid-in Capital | $719M | $701M | $668M | $500M | $486M | $7M | |
| Retained Earnings | $-597M | $-448M | $-299M | $-197M | $-98M | $-31M | |
| AOCI | $103.0K | $255.0K | $30.0K | $-2M | $-135.0K | $0 | |
| Stockholders' Equity | $122M | $253M | $368M | $301M | $388M | $-23M | |
| Liabilities + Equity | $175M | $313M | $432M | $374M | $442M | $36M | |
| Shares Outstanding | 95,143,690 | 92,378,577 | 88,448,948 | 61,029,184 | 60,263,158 | 9,710,829 |
현금 흐름 14
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $4M | $4M | $4M | $2M | $984.0K | $900.0K | |
| Stock-based Comp | $13M | $17M | $14M | $12M | $3M | $1M | |
| Deferred Tax | $-551.0K | $-10.0K | $178.0K | $-95.0K | $320.0K | $-919.0K | |
| Other Non-cash | $21M | $-10M | $-9M | $-5M | $30M | · | |
| Operating Cash Flow | $-111M | $-138M | $-93M | $-91M | $-33M | $-33M | |
| CapEx | $1M | $5M | $12M | $6M | $2M | $317.0K | |
| Investing Cash Flow | $102M | $87M | $-68M | $-93M | $-176M | $6M | |
| Stock Issued | $4M | $15M | $1M | $0 | · | · | |
| Net Stock Activity | $4M | $15M | $1M | · | · | · | |
| Financing Cash Flow | $5M | $17M | $154M | $2M | $433M | $2M | |
| Net Change in Cash | $-4M | $-35M | $-7M | $-182M | $225M | $-25M | |
| Taxes Paid | · | $0 | $170.0K | $0 | $11.0K | $21.0K | |
| Free Cash Flow | $-112M | $-143M | $-105M | $-97M | $-35M | · | |
| Levered FCF | · | · | · | · | $-35M | · |
수익성 7
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | -1329.4% | -1667.2% | -336.6% | -768.2% | -697.8% | · | |
| Net Margin | -1327.4% | -1491.9% | -296.1% | -717.8% | -697.3% | · | |
| Pretax Margin | -1332.3% | -1492.0% | -295.5% | -717.3% | -693.9% | · | |
| EBITDA Margin | -1296.7% | -1627.9% | -326.4% | -756.5% | -687.6% | · | |
| ROA | -60.6% | -40.0% | -25.3% | -24.4% | -28.0% | · | |
| ROE | -102.8% | -55.8% | -26.6% | -31.8% | -16.9% | · | |
| ROIC | -121.0% | -65.9% | -31.6% | -35.4% | -17.3% | · |
유동성 및 지급능력 3
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 5.7 | 7.2 | 12.0 | 9.3 | 15.1 | · | |
| Quick Ratio | 0.5 | 0.5 | 1.8 | 2.1 | 9.4 | · | |
| Interest Coverage | · | · | · | · | -8372.4 | · |
효율성 2
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | · | |
| Receivables Turnover | 66.8 | 48.4 | 197.0 | 20.4 | 14.7 | · |
성장률 3
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | 11.7% | -71.0% | 148.9% | 44.3% | -22.4% | · | |
| Revenue CAGR 3Y | -7.0% | 1.4% | 40.8% | · | · | · | |
| Revenue CAGR 5Y | -2.0% | · | · | · | · | · |
가치 평가 (TTM) 10
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $11M | $10M | $34M | $14M | $10M | · | |
| Net Income TTM | $-148M | $-149M | $-102M | $-99M | $-67M | · | |
| Market Cap | $151M | $147M | $507M | $383M | $909M | · | |
| P/E | -1.0 | -1.0 | -4.2 | -3.8 | -7.2 | · | |
| P/S | 13.6 | 14.7 | 14.7 | 27.7 | 94.7 | · | |
| P/B | 1.2 | 0.6 | 1.4 | 1.3 | 2.3 | · | |
| P / Tangible Book | 1.2 | 0.6 | 1.4 | 1.3 | 2.3 | · | |
| P / Cash Flow | -1.4 | -1.1 | -5.4 | -4.2 | -28.0 | · | |
| P / FCF | -1.3 | -1.0 | -4.8 | -3.9 | -26.3 | · | |
| Earnings Yield | -100.0% | -103.8% | -24.1% | -26.1% | -14.0% | · |
손익계산서 13
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1M | $2M | $4M | $2M | $3M | $2M | $2M | $2M | $3M | $2M | $4M | $24M | $4M | $4M | $4M | $3M | |
| R&D Expense | $19M | $21M | $24M | $22M | $28M | $36M | $30M | $30M | $35M | $34M | $31M | $29M | $27M | $26M | $26M | $20M | |
| SG&A Expense | $8M | $8M | $9M | $9M | $10M | $10M | $10M | $10M | $11M | $15M | $10M | $10M | $10M | $9M | $9M | $10M | |
| Operating Expenses | $27M | $29M | $32M | $32M | $50M | $45M | $41M | $40M | $47M | $48M | $41M | $38M | $37M | $35M | $34M | $30M | |
| Operating Income | $-25M | $-26M | $-28M | $-29M | $-48M | $-43M | $-39M | $-38M | $-44M | $-46M | $-37M | $-15M | $-33M | $-31M | $-31M | $-27M | |
| Other Non-op | $1M | $1M | $1M | $2M | $-7M | $3M | $3M | $4M | $6M | $5M | $3M | $5M | $3M | $3M | $4M | $-110.0K | |
| Income Tax | · | $0 | $-550.0K | $0 | · | $0 | $-9.0K | $0 | $0 | $0 | $193.0K | $0 | $0 | $0 | $70.0K | $0 | |
| Net Income | $-24M | $-25M | $-26M | $-28M | $-54M | $-40M | $-35M | $-35M | $-38M | $-41M | $-35M | $-10M | $-30M | $-28M | $-27M | $-27M | |
| EPS (Basic) | $-0.24 | $-0.26 | $-0.28 | $-0.30 | $-0.58 | $-0.43 | $-0.39 | $-0.38 | $-0.42 | $-0.46 | $-0.32 | $-0.12 | $-0.48 | $-0.46 | $-0.44 | $-0.44 | |
| EPS (Diluted) | $-0.24 | $-0.26 | $-0.28 | $-0.30 | $-0.58 | $-0.43 | $-0.39 | $-0.38 | $-0.42 | $-0.46 | $-0.32 | $-0.12 | $-0.48 | $-0.46 | $-0.44 | $-0.44 | |
| Shares (Basic) | 100,985,698 | 95,861,716 | -185,612,007 | 93,293,099 | 93,028,698 | 92,679,493 | -179,781,844 | 90,455,900 | 90,340,932 | 89,302,937 | -132,580,843 | 83,783,992 | 61,417,934 | 61,186,514 | -121,389,647 | 60,886,921 | |
| Shares (Diluted) | 100,985,698 | 95,861,716 | -185,612,007 | 93,293,099 | 93,028,698 | 92,679,493 | -179,781,844 | 90,455,900 | 90,340,932 | 89,302,937 | -132,580,843 | 83,783,992 | 61,417,934 | 61,186,514 | -121,389,647 | 60,886,921 | |
| EBITDA | $-25M | $-26M | · | $-29M | $-48M | $-42M | · | $-38M | $-44M | $-45M | · | $-15M | · | · | · | $-27M |
대차대조표 22
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $26M | $12M | $12M | $11M | $25M | $29M | $16M | $32M | $38M | $49M | $51M | $104M | $66M | $53M | $58M | $82M | |
| Receivables | $203.0K | $227.0K | $69.0K | $242.0K | $71.0K | $88.0K | $265.0K | $184.0K | $215.0K | $917.0K | $148.0K | $1M | $766.0K | $2M | $202.0K | $397.0K | |
| Prepaid Expense | $2M | $2M | $3M | $5M | $6M | $6M | $7M | $7M | $6M | $7M | $6M | $7M | $6M | $6M | $8M | $9M | |
| Current Assets | $117M | $122M | $145M | $156M | $193M | $217M | $219M | $237M | $271M | $305M | $339M | $351M | $269M | $239M | $260M | $307M | |
| PP&E (Net) | $5M | $6M | $7M | $8M | $8M | $19M | $19M | $20M | $20M | $19M | $18M | $17M | $15M | $13M | $11M | $9M | |
| PP&E (Gross) | $20M | $20M | $20M | $20M | $20M | $33M | $32M | $31M | $31M | $29M | $27M | $25M | $22M | $19M | $16M | $14M | |
| Accum. Depreciation | $15M | $14M | $14M | $13M | $12M | $14M | $13M | $12M | $11M | $10M | $9M | $8M | $7M | $6M | $6M | $5M | |
| Other Non-current Assets | $2M | $2M | $2M | $4M | $4M | $5M | $6M | $5M | $2M | $2M | $2M | $2M | $1M | $1M | $2M | $1M | |
| Total Assets | $143M | $149M | $175M | $195M | $221M | $274M | $313M | $344M | $373M | $407M | $432M | $458M | $350M | $347M | $374M | $399M | |
| Accounts Payable | $3M | $4M | $6M | $4M | $3M | $4M | $2M | $3M | $3M | $6M | $3M | $2M | $4M | $3M | $1M | $1M | |
| Accrued Liabilities | $13M | $14M | $17M | $19M | $21M | $20M | $24M | $25M | $24M | $19M | $21M | $18M | $16M | $13M | $16M | $15M | |
| Current Liabilities | $18M | $20M | $25M | $28M | $29M | $28M | $31M | $32M | $31M | $29M | $28M | $25M | $34M | $27M | $28M | $29M | |
| Capital Leases | $25M | $26M | $26M | $23M | $24M | $24M | $25M | $25M | $26M | $26M | $26M | $26M | $26M | $26M | $27M | $27M | |
| Deferred Tax | · | · | $0 | $548.0K | $548.0K | $548.0K | $548.0K | $557.0K | $557.0K | $556.0K | $557.0K | $381.0K | $380.0K | $382.0K | $381.0K | $475.0K | |
| Total Liabilities | $45M | $47M | $53M | $53M | $55M | $56M | $60M | $63M | $62M | $64M | $64M | $59M | $80M | $69M | $73M | $75M | |
| Common Stock | $11.0K | $10.0K | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $8.0K | $8.0K | $6.0K | $6.0K | $6.0K | $6.0K | |
| Paid-in Capital | $744M | $724M | $719M | $712M | $709M | $705M | $701M | $693M | $689M | $684M | $668M | $664M | $525M | $504M | $500M | $496M | |
| Retained Earnings | $-646M | $-622M | $-597M | $-570M | $-542M | $-488M | $-448M | $-413M | $-378M | $-341M | $-299M | $-265M | $-255M | $-225M | $-197M | $-170M | |
| AOCI | $-71.0K | $-23.0K | $103.0K | $93.0K | $40.0K | $167.0K | $255.0K | $789.0K | $-319.0K | $-322.0K | $30.0K | $-981.0K | $-1M | $-730.0K | $-2M | $-2M | |
| Stockholders' Equity | $98M | $102M | $122M | $142M | $166M | $217M | $253M | $281M | $310M | $343M | $368M | $398M | $269M | $278M | $301M | $324M | |
| Liabilities + Equity | $143M | $149M | $175M | $195M | $221M | $274M | $313M | $344M | $373M | $407M | $432M | $458M | $350M | $347M | $374M | $399M | |
| Shares Outstanding | 105,995,653 | 96,951,234 | 95,143,690 | 93,468,038 | 93,123,239 | 93,004,602 | 92,378,577 | 90,552,687 | 90,362,771 | 90,314,501 | 88,448,948 | 88,430,609 | 66,100,039 | 61,323,523 | 61,029,184 | 60,986,936 |
현금 흐름 13
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $625.0K | $649.0K | $682.0K | $631.0K | $1M | $1M | $1M | $1M | $856.0K | $710.0K | $740.0K | $2M | $617.0K | $589.0K | $506.0K | $450.0K | |
| Stock-based Comp | $2M | $2M | $3M | $3M | $3M | $4M | $4M | $4M | $5M | $4M | $4M | $3M | $4M | $3M | $3M | $3M | |
| Restructuring | · | · | · | · | · | · | · | $600.0K | · | · | · | · | · | · | · | · | |
| Other Non-cash | · | $-5M | · | · | · | $-2M | · | · | · | $-667.0K | · | · | · | · | · | · | |
| Operating Cash Flow | $-23M | $-27M | $-21M | $-25M | $-28M | $-37M | $-35M | $-33M | $-33M | $-37M | $-21M | $-29M | $-15M | $-28M | $-25M | $-22M | |
| CapEx | $1.0K | $72.0K | $-216.0K | $115.0K | $418.0K | $1M | $518.0K | $673.0K | $2M | $1M | $2M | $5M | $3M | $2M | $2M | $1M | |
| Investing Cash Flow | $19M | $24M | $18M | $11M | $24M | $49M | $16M | $27M | $21M | $23M | $-31M | $-68M | $11M | $21M | $1M | $-8M | |
| Stock Issued | $18M | $2M | $4M | $0 | $0 | $0 | $4M | $0 | $0 | $11M | $0 | $-1.0K | $-115.0K | $1M | $0 | $0 | |
| Net Stock Activity | · | $2M | · | · | · | $0 | · | · | · | $11M | · | · | · | · | · | · | |
| Financing Cash Flow | $18M | $3M | $4M | $277.0K | $6.0K | $468.0K | $4M | $244.0K | $132.0K | $12M | $-43.0K | $135M | $18M | $2M | $127.0K | $654.0K | |
| Net Change in Cash | $14M | $-303.0K | $1M | $-14M | $-4M | $13M | $-16M | $-6M | $-12M | $-2M | $-53M | $38M | $13M | $-6M | $-24M | $-30M | |
| Taxes Paid | · | · | · | · | · | · | · | $0 | · | · | $0 | $0 | · | · | $0 | $0 | |
| Free Cash Flow | · | $-27M | · | · | · | $-38M | · | · | · | $-39M | · | · | · | · | · | · |
수익성 5
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1690.4% | -1096.4% | · | -1337.6% | -1784.0% | -1823.8% | · | -1889.2% | -1255.8% | -1893.9% | · | -61.8% | · | · | · | -803.4% | |
| Net Margin | -1619.9% | -1046.5% | · | -1253.3% | -2028.4% | -1699.6% | · | -1713.6% | -1088.2% | -1697.6% | · | -42.3% | · | · | · | -806.8% | |
| EBITDA Margin | -1690.4% | -1069.3% | · | -1337.6% | -1784.0% | -1774.2% | · | -1889.2% | -1255.8% | -1864.6% | · | -61.8% | · | · | · | -803.4% | |
| ROA | -13.4% | -11.9% | · | -10.2% | -18.2% | -11.8% | · | -8.6% | -10.4% | -10.9% | · | -2.3% | · | · | · | -6.2% | |
| ROE | -18.4% | -15.7% | · | -13.0% | -22.7% | -14.3% | · | -10.2% | -13.0% | -13.3% | · | -2.8% | · | · | · | -7.3% |
유동성 및 지급능력 2
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.5 | 6.2 | · | 5.5 | 6.7 | 7.6 | · | 7.4 | 8.8 | 10.5 | · | 14.3 | · | · | · | 10.7 | |
| Quick Ratio | 1.5 | 0.6 | · | 0.4 | 0.9 | 1.0 | · | 1.0 | 1.2 | 1.7 | · | 4.3 | · | · | · | 2.9 |
효율성 2
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.1 | · | · | · | 0.0 | |
| Receivables Turnover | 10.9 | 15.2 | · | 10.3 | 18.7 | 4.7 | · | 3.1 | 7.1 | 2.0 | · | 30.9 | · | · | · | 6.8 |
가치 평가 (TTM) 10
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $9M | $10M | · | $9M | $11M | $10M | · | $32M | $33M | $33M | · | $34M | $15M | $14M | · | $13M | |
| Net Income TTM | $-131M | $-147M | · | $-156M | $-166M | $-154M | · | $-124M | $-118M | $-109M | · | $-94M | $-111M | $-100M | · | $-91M | |
| Market Cap | $187M | $184M | · | $218M | $117M | $85M | · | $177M | $148M | $464M | · | $423M | · | · | · | $643M | |
| P/E | -1.3 | -1.2 | · | -1.4 | -0.7 | -0.5 | · | -1.4 | -1.1 | -3.4 | · | -3.2 | -2.3 | -3.2 | · | -6.4 | |
| P/S | 21.3 | 19.2 | · | 23.6 | 11.2 | 8.3 | · | 5.6 | 4.4 | 13.9 | · | 12.4 | · | · | · | 50.6 | |
| P/B | 1.9 | 1.8 | · | 1.5 | 0.7 | 0.4 | · | 0.6 | 0.5 | 1.4 | · | 1.1 | · | · | · | 2.0 | |
| P / Tangible Book | 1.9 | 1.8 | · | 1.5 | 0.7 | 0.4 | · | 0.6 | 0.5 | 1.4 | · | 1.1 | 1.0 | 1.2 | · | 2.0 | |
| P / Cash Flow | · | -6.8 | · | · | · | -2.3 | · | · | · | -12.5 | · | · | · | · | · | · | |
| P / FCF | · | -6.8 | · | · | · | -2.2 | · | · | · | -12.0 | · | · | · | · | · | · | |
| Earnings Yield | -78.4% | -82.6% | · | -72.5% | -143.7% | -185.1% | · | -70.4% | -90.2% | -29.6% | · | -31.4% | -42.8% | -31.3% | · | -15.7% |
재무제표 손익계산서, 대차대조표, 현금흐름 — 연간, 지난 5년
손익계산서
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 매출 | $11M | $10M | $34M | $14M | $10M |
| 영업이익률 % | -1329.4% | -1667.2% | -336.6% | -768.2% | -697.8% |
| 순이익 | $-148M | $-149M | $-102M | $-99M | $-67M |
| 희석 EPS | $-1.59 | $-1.65 | $-1.38 | $-1.64 | $-2.11 |
대차대조표
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 유동비율 | 5.7 | 7.2 | 12.0 | 9.3 | 15.1 |
| 당좌 비율 | 0.5 | 0.5 | 1.8 | 2.1 | 9.4 |
현금 흐름
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 잉여현금흐름 | $-112M | $-143M | $-105M | $-97M | $-35M |
나의 지표 나만의 관심 목록 — 전체 기본 재무제표에서 선택한 항목
📊
중요한 지표를 선택하세요 — 위 전체 기본 재무제표의 아무 행 옆에 있는 ➕를 클릭하세요.
선택 항목이 저장되어 모든 티커에서 유지됩니다.
기관 투자자 (13F) 149개의 제출자 · $60.8M 전체 · 기준일 2026년 6월 30일
분기별 SEC 양식 13F에서 이 주식을 보유하고 있다고 보고하는 기관. 롱 포지션만 해당하며, 단일 제출자는 별도의 옵션 레그에 대해 두 번 나타날 수 있습니다. 대규모 상쇄 풋/콜 포지션은 일반적으로 방향성에 대한 확신보다는 시장 조성 또는 헤지된 재고를 반영합니다.
기관 활동 — Q2 2026 대 이전 분기
| 신규 포지션 | 청산 포지션 | 증가함 | 감소 | 순주식 변동 |
|---|---|---|---|---|
| 29 (+3 이전 분기 대비) | 22 (+11 이전 분기 대비) | 38 (+5 이전 분기 대비) | 31 (-5 이전 분기 대비) | +8.4M |
Q1 2026 대비 비교. SEC 양식 13F 제출은 분기 말로부터 45일 이내에 마감되며, 지연 제출자를 위한 짧은 유예 기간이 추가됩니다. 해당 기간 내에 있는 분기는 가장 최근에 완전히 보고된 쌍을 선호하여 건너뜁니다.
| 기관 | 가치 | 주식 | % 추적된 13F 중 | 유형 |
|---|---|---|---|---|
| Pfizer Inc | $7,879,924 | 4,690,431 | 12.97% | 주식 |
| VANGUARD CAPITAL MANAGEMENT LLC | $7,407,080 | 4,208,568 | 12.19% | 주식 |
| MACKENZIE FINANCIAL CORP | $6,425,401 | 3,650,796 | 10.57% | 주식 |
| RENAISSANCE TECHNOLOGIES LLC | $4,881,439 | 2,773,545 | 8.03% | 주식 |
| Kynam Capital Management, LP | $4,405,812 | 2,503,302 | 7.25% | 주식 |
| GEODE CAPITAL MANAGEMENT, LLC | $3,589,256 | 2,038,889 | 5.91% | 주식 |
| STATE STREET CORP | $2,873,929 | 1,632,914 | 4.73% | 주식 |
| TWO SIGMA INVESTMENTS, LP | $1,841,451 | 1,046,279 | 3.03% | 주식 |
| TWO SIGMA ADVISERS, LP | $1,773,963 | 1,115,700 | 2.92% | 주식 |
| DIMENSIONAL FUND ADVISORS LP | $1,522,646 | 865,140 | 2.51% | 주식 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1,365,424 | 775,809 | 2.25% | 주식 |
| MAVERICK CAPITAL LTD | $1,148,474 | 652,542 | 1.89% | 주식 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1,080,290 | 613,801 | 1.78% | 주식 |
| VANGUARD FIDUCIARY TRUST CO | $1,067,243 | 606,388 | 1.76% | 주식 |
| Qube Research & Technologies Ltd | $960,529 | 545,755 | 1.58% | 주식 |
| 72 Investment Holdings, LLC | $834,358 | 474,067 | 1.37% | 주식 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $723,323 | 410,979 | 1.19% | 주식 |
| Green Alpha Advisors, LLC | $641,210 | 364,324 | 1.06% | 주식 |
| PFM Health Sciences, LP | $624,249 | 354,687 | 1.03% | 주식 |
| BANK OF AMERICA CORP /DE/ | $492,297 | 279,714 | 0.81% | 주식 |
| XTX Topco Ltd | $473,716 | 269,157 | 0.78% | 주식 |
| Bruce & Co., Inc. | $440,000 | 250,000 | 0.72% | 주식 |
| Man Group plc | $422,516 | 240,066 | 0.70% | 주식 |
| WELLS FARGO & COMPANY/MN | $379,379 | 215,556 | 0.62% | 주식 |
| MILESTONE ASSET MANAGEMENT, LLC | $352,150 | 200,085 | 0.58% | 주식 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $305,140 | 173,375 | 0.50% | 주식 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $291,129 | 165,414 | 0.48% | 주식 |
| Susquehanna Portfolio Strategies, LLC | $279,131 | 158,597 | 0.46% | 주식 |
| Graham Capital Management, L.P. | $274,409 | 155,914 | 0.45% | 주식 |
| AMERICAN CENTURY COMPANIES INC | $247,421 | 140,580 | 0.41% | 주식 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $232,320 | 132,000 | 0.38% | 주식 |
| Nuveen, LLC | $217,388 | 123,516 | 0.36% | 주식 |
| CITADEL ADVISORS LLC | $217,008 | 123,300 | 0.36% | 콜 옵션 |
| Cubist Systematic Strategies, LLC | $216,135 | 92,762 | 0.36% | 주식 |
| LPL Financial LLC | $216,082 | 122,774 | 0.36% | 주식 |
| NANO CAP NEW MILLENNIUM GROWTH FUND L P | $206,800 | 117,500 | 0.34% | 주식 |
| DEUTSCHE BANK AG\ | $157,652 | 89,575 | 0.26% | 주식 |
| Quadrature Capital Ltd | $156,603 | 88,979 | 0.26% | 주식 |
| BlackRock, Inc. | $154,524 | 87,798 | 0.25% | 주식 |
| CANADA PENSION PLAN INVESTMENT BOARD | $142,736 | 81,100 | 0.23% | 주식 |
| Keystone Financial Group | $142,252 | 80,825 | 0.23% | 주식 |
| Bank of New York Mellon Corp | $140,327 | 79,731 | 0.23% | 주식 |
| BNP PARIBAS FINANCIAL MARKETS | $124,777 | 70,896 | 0.21% | 주식 |
| RHUMBLINE ADVISERS | $120,681 | 68,571 | 0.20% | 주식 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $120,032 | 68,200 | 0.20% | 콜 옵션 |
| Nelson Capital Management, LLC | $103,286 | 58,685 | 0.17% | 주식 |
| Nuveen Asset Management, LLC | $102,339 | 64,364 | 0.17% | 주식 |
| GOLDMAN SACHS GROUP INC | $99,083 | 56,297 | 0.16% | 주식 |
| CITIGROUP INC | $98,579 | 56,011 | 0.16% | 주식 |
| MILLENNIUM MANAGEMENT LLC | $90,061 | 51,171 | 0.15% | 주식 |
| COMMONWEALTH EQUITY SERVICES, LLC | $84,320 | 47,908 | 0.14% | 주식 |
| JANE STREET GROUP, LLC | $80,432 | 45,700 | 0.13% | 풋 옵션 |
| SEI INVESTMENTS CO | $73,813 | 41,939 | 0.12% | 주식 |
| BARCLAYS PLC | $71,240 | 40,477 | 0.12% | 주식 |
| CITADEL ADVISORS LLC | $71,130 | 40,415 | 0.12% | 주식 |
| ALLIANCEBERNSTEIN L.P. | $70,452 | 37,080 | 0.12% | 주식 |
| RBF Capital, LLC | $70,400 | 40,000 | 0.12% | 주식 |
| Point72 Asia (Singapore) Pte. Ltd. | $69,102 | 29,658 | 0.11% | 주식 |
| PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | $68,867 | 39,129 | 0.11% | 주식 |
| JANE STREET GROUP, LLC | $66,704 | 37,900 | 0.11% | 콜 옵션 |
| Invesco Ltd. | $64,449 | 36,619 | 0.11% | 주식 |
| Connor, Clark & Lunn Investment Management Ltd. | $62,503 | 35,513 | 0.10% | 주식 |
| NEW YORK STATE COMMON RETIREMENT FUND | $62,304 | 35,400 | 0.10% | 주식 |
| HSBC HOLDINGS PLC | $61,856 | 34,460 | 0.10% | 주식 |
| Vanguard Personalized Indexing Management, LLC | $61,098 | 34,715 | 0.10% | 주식 |
| PRUDENTIAL FINANCIAL INC | $60,500 | 34,375 | 0.10% | 주식 |
| US BANCORP \DE\ | $60,306 | 34,265 | 0.10% | 주식 |
| CITADEL ADVISORS LLC | $60,016 | 34,100 | 0.10% | 풋 옵션 |
| &PARTNERS | $57,209 | 32,505 | 0.09% | 주식 |
| Prime Capital Investment Advisors, LLC | $56,874 | 32,315 | 0.09% | 주식 |
| Thrive Wealth Management, LLC | $56,320 | 32,000 | 0.09% | 주식 |
| MORGAN STANLEY | $54,342 | 30,876 | 0.09% | 주식 |
| JANE STREET GROUP, LLC | $53,383 | 30,331 | 0.09% | 주식 |
| AMERIPRISE FINANCIAL INC | $51,797 | 29,430 | 0.09% | 주식 |
| Vanguard Global Advisers, LLC | $51,218 | 29,101 | 0.08% | 주식 |
| CREDIT AGRICOLE S A | $51,040 | 29,000 | 0.08% | 주식 |
| Police & Firemen's Retirement System of New Jersey | $47,668 | 27,084 | 0.08% | 주식 |
| VANGUARD GROUP INC | $46,271 | 29,101 | 0.08% | 주식 |
| Creative Planning | $44,880 | 25,500 | 0.07% | 주식 |
| Spark Investment Management LLC | $41,536 | 23,600 | 0.07% | 주식 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $41,297 | 23,464 | 0.07% | 주식 |
| MARSHALL WACE, LLP | $40,079 | 22,773 | 0.07% | 주식 |
| LIBERTY WEALTH MANAGEMENT LLC | $37,050 | 19,500 | 0.06% | 주식 |
| Next Capital Management LLC | $35,200 | 20,000 | 0.06% | 주식 |
| INTECH INVESTMENT MANAGEMENT LLC | $34,971 | 19,870 | 0.06% | 주식 |
| FMR LLC | $30,034 | 17,065 | 0.05% | 주식 |
| HighTower Advisors, LLC | $29,804 | 16,934 | 0.05% | 주식 |
| China Universal Asset Management Co., Ltd. | $27,782 | 15,785 | 0.05% | 주식 |
| Point72 Asset Management, L.P. | $27,753 | 15,769 | 0.05% | 주식 |
| ProShare Advisors LLC | $26,890 | 15,279 | 0.04% | 주식 |
| Modern Wealth Management, LLC | $26,400 | 15,000 | 0.04% | 주식 |
| NORTHERN TRUST CORP | $25,221 | 14,330 | 0.04% | 주식 |
| GREAT VALLEY ADVISOR GROUP, INC. | $25,160 | 14,314 | 0.04% | 주식 |
| PINNACLE ASSOCIATES LTD | $22,709 | 12,903 | 0.04% | 주식 |
| Pinnacle Wealth Management Advisory Group, LLC | $22,709 | 12,903 | 0.04% | 주식 |
| AXQ CAPITAL, LP | $21,558 | 12,249 | 0.04% | 주식 |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $21,191 | 11,008 | 0.03% | 주식 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $20,592 | 11,700 | 0.03% | 풋 옵션 |
| FSA Wealth Management LLC | $20,108 | 8,630 | 0.03% | 주식 |
| HBK Sorce Advisory LLC | $19,874 | 12,344 | 0.03% | 주식 |
회사 내부자 15 명의 내부자 · 6 임원 · 7 이사
| 내부자 | 역할 | 마지막 활동 | 보유 주식 수 | 매수 12개월 | 매도 12개월 | 순매수/매도 12개월 |
|---|---|---|---|---|---|---|
| Rachel E. Haurwitz | President and CEO | 2022년 5월 9일 M | 20,000 | 0 | 0 | $0 |
| Jason O'Byrne | Chief Financial Officer | 2022년 2월 8일 M | 24,336 | 0 | 0 | $0 |
| Steven Kanner | Chief Scientific Officer | 2022년 8월 25일 M | 302,059 | 0 | 0 | $0 |
| Ruhi Ahmad Khan | Chief Business Officer | 2022년 8월 22일 A | — | 0 | 0 | $0 |
| Ryan Fischesser | VP of Finance and Controller | 2022년 8월 22일 A | 120,366 | 0 | 0 | $0 |
| Syed Ali-Aamir Rizvi | Chief Medical Officer | 2022년 1월 25일 A | 65,000 | 0 | 0 | $0 |
| David Lee Johnson | 이사 | 2022년 5월 18일 A | — | 0 | 0 | $0 |
| Ran Zheng | 이사 | 2021년 12월 20일 A | — | 0 | 0 | $0 |
| Nancy Whiting | 이사 | 2021년 12월 20일 A | — | 0 | 0 | $0 |
| Natalie Sacks | 이사 | 2021년 12월 20일 A | — | 0 | 0 | $0 |
| Scott Braunstein | 이사 | 2021년 12월 20일 A | — | 0 | 0 | $0 |
| Dara Richardson-Heron | 이사 | 2021년 11월 11일 A | — | 0 | 0 | $0 |
| Barbara G Mcclung | — | 2026년 2월 20일 A | 481,564 | 0 | 1 | $-13,598 |
| Andrew Guggenhime | — | 2026년 2월 20일 A | — | 0 | 0 | $0 |
| FMR LLC | — | 2021년 7월 27일 C | 1,464,775 | 0 | 0 | $0 |
SEC 양식 3/4/5 제출 서류 기준 내부자; 순매수/매도는 공개 시장 거래만 해당
행동주의자 및 5% 이상 소유자 1 보유
SEC 서류 13D를 제출한 투자자 — 발행인에 영향을 미치려는 의도로 5% 이상의 실질 소유권(행동주의 지분, 이사회 캠페인, M&A). 각 행은 해당 제출자의 포지션에 대한 가장 최근에 알려진 상태를 보여줍니다.
| 제출자 | 제출됨 | 지분 | 상태 | 목적 | 제출 |
|---|---|---|---|---|---|
| The City Canyon Family Trust dated May 31, 2021, Rachel E. Haurwitz, Felix Adler ×3 제출 서류 | 2025년 4월 25일 | 5.00% | 최초 제출 | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF 보유 현황 20 ETF 보유
가중치는 직접적인 주식 보유(N-PORT)만 반영합니다. 레버리지 또는 파생 상품 기반 펀드는 표시되지 않은 추가 스왑 노출을 보유할 수 있습니다.
| 펀드 | 비중 | 단위 | 기준일 | 출처 |
|---|---|---|---|---|
| GNOM · Global X Funds | 0.29% | 68,184 NS | 2026년 5월 31일 | N-PORT |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0.09% | 165,499 SH | 2026년 8월 8일 | 일간 |
| IWC · iShares Trust | 0.03% | 308,420 SH | 2026년 8월 8일 | 일간 |
| AVSC · AMERICAN CENTURY ETF TRUST | 0.01% | 133,553 NS | 2026년 5월 31일 | N-PORT |
| IBB · iShares Trust | 0.01% | 649,654 SH | 2026년 8월 8일 | 일간 |
| BIB · ProShares Trust | 0.01% | 3,454 NS | 2026년 5월 31일 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0.01% | 5,348 SH | 2026년 8월 8일 | 일간 |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.01% | 79,869 SH | 2026년 8월 8일 | 일간 |
| IWN · iShares Trust | 0.01% | 872,357 SH | 2026년 8월 8일 | 일간 |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.00% | 82,261 SH | 2026년 8월 8일 | 일간 |
| IWM · iShares Trust | 0.00% | 2,246,082 SH | 2026년 8월 8일 | 일간 |
| SCHA · SCHWAB STRATEGIC TRUST | 0.00% | 425,172 NS | 2026년 5월 31일 | N-PORT |
| DFAS · Dimensional ETF Trust | 0.00% | 217,292 NS | 2026년 4월 30일 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.00% | 9,000 NS | 2026년 4월 30일 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.00% | 95,887 NS | 2026년 4월 30일 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0.00% | 78,996 NS | 2026년 5월 31일 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 1,113,215 SH | 2026년 8월 8일 | 일간 |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 3,013,973 SH | 2026년 8월 8일 | 일간 |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.00% | 524,917 SH | 2026년 8월 8일 | 일간 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 9,015 SH | 2026년 8월 8일 | 일간 |